All In Biotech

Drug Trial Radar · NCT07128199

A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Versus Placebo in Early Stage NSCLC Patients With Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

360

Planned (sponsor's estimate)

Start

Dec 22, 2025

Primary completion

Oct 1, 2029

Study completion Oct 1, 2032

Sponsor

Lead sponsor
Taiho Oncology, Inc.Industry
Sponsor type
Industry
First posted
Aug 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy of zipalertinib versus placebo in participants with early stage resected non-small cell lung cancer (NSCLC) harboring uncommon epidermal growth factor receptor mutation (EGFRmt).

Conditions

  • Lung Cancer
  • Adjuvant
  • Post-surgical
  • EGFR
  • Exon 20
  • Early Stage Lung Cancer
  • Uncommon EGFR Mutations
  • NSCLC, Early Stage

Interventions

  • TAS6417Drug

    Oral tablets.

  • Zipalertinib Matching-placeboDrug

    Oral tablets.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease-free Survival (DFS) as Assessed by the InvestigatorTime frame: Up to 5 years

Locations

253 sites in 24 countries. Site status is shown where the registry gives one.

  • Alaska Oncology and Hematology

    Anchorage, Alaska · Recruiting

  • City of Hope Comprehensive Cancer Center - Duarte

    Duarte, California · Not yet recruiting

  • City of Hope Comprehensive Cancer Center Orange County Lennar Foundation Cancer Center

    Irvine, California · Not yet recruiting

  • Scripps Clinic Torrey Pines

    La Jolla, California · Not yet recruiting

  • Kaiser Permanente - Vallejo Medical Center

    Vallejo, California · Not yet recruiting

  • Georgetown University School of Medicine

    Washington D.C., District of Columbia · Recruiting

  • D&H Cancer Research Center - Margate

    Margate, Florida · Recruiting

  • Alpha Oncology Research

    Orange City, Florida · Recruiting

  • City of Hope - Atlanta

    Newnan, Georgia · Not yet recruiting

  • University of Illinois Medical Center

    Chicago, Illinois · Recruiting

  • Profound Research LLC at Michigan Hematology and Oncology Consultants

    Dearborn, Michigan · Recruiting

  • Henry Ford Health System

    Detroit, Michigan · Not yet recruiting

  • Memorial Sloan Kettering Cancer Center - Basking Ridge

    Basking Ridge, New Jersey · Not yet recruiting

  • Memorial Sloan Kettering Cancer Center - Monmouth

    Middletown, New Jersey · Not yet recruiting

  • Memorial Sloan Kettering Cancer Center - Bergen

    Montvale, New Jersey · Not yet recruiting

  • Memorial Sloan Kettering Cancer Center - Commack

    Commack, New York · Not yet recruiting

  • Memorial Sloan Kettering Cancer Center - Westchester

    East White Plains, New York · Not yet recruiting

  • Long Island Jewish Medical Center

    Lake Success, New York · Not yet recruiting

  • Perlmutter Cancer Center - 34th Street

    New York, New York · Not yet recruiting

  • Memorial Sloan Kettering Cancer Center - New York

    New York, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center - Nassau

    Uniondale, New York · Not yet recruiting

  • Atrium Health Wake Forest Baptist - Comprehensive Cancer Center

    Charlotte, North Carolina · Not yet recruiting

  • Durham Veterans Affairs Health Care System

    Durham, North Carolina · Not yet recruiting

  • Gabrail Cancer and Research Center

    Canton, Ohio · Recruiting

  • Gibbs Cancer Center and Research Institute Spartanburg

    Spartanburg, South Carolina · Not yet recruiting

  • Virginia Cancer Specialists - Arlington Office

    Arlington, Virginia · Not yet recruiting

  • Virginia Cancer Specialists - Fairfax Office

    Fairfax, Virginia · Recruiting

  • Virginia Cancer Specialists - Bristow Office

    Manassas, Virginia · Not yet recruiting

  • Virginia Cancer Specialists - Reston

    Reston, Virginia · Not yet recruiting

  • Virginia Cancer Specialists - Woodbridge Office

    Woodbridge, Virginia · Not yet recruiting

  • Instituto Argentino de Diagnóstico y Tratamiento

    Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina · Not yet recruiting

  • Centro de Investigación Pergamino SA

    Pergamino, Buenos Aires, Argentina · Not yet recruiting

  • Hospital Universitario Austral

    Pilar, Buenos Aires, Argentina · Not yet recruiting

  • CEMAIC - Centro de Especialidades Médicas Ambulatorias e Investigación Clínica

    Córdoba, Córdoba Province, Argentina · Not yet recruiting

  • Bankstown-Lidcombe Hospital

    Bankstown, New South Wales, Australia · Not yet recruiting

  • GenesisCare - North Shore

    St Leonards, New South Wales, Australia · Recruiting

  • Saint John of God - Subiaco Hospital

    Subiaco, Western Australia, Australia · Recruiting

  • Universitair Ziekenhuis Antwerpen

    Edegem, Antwerpen, Belgium · Not yet recruiting

  • Algemeen Ziekenhuis Sint-Maarten

    Mechelen, Antwerpen, Belgium · Not yet recruiting

  • Universitair Ziekenhuis (UZ) Leuven - Campus Gasthuisberg

    Leuven, Flemish Brabant, Belgium · Not yet recruiting

Showing 40 of 253 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.